Neuropeptide Y receptors: a promising target for cancer imaging and therapy
- PMID: 26816643
- PMCID: PMC4669009
- DOI: 10.1093/rb/rbv013
Neuropeptide Y receptors: a promising target for cancer imaging and therapy
Abstract
Neuropeptide Y (NPY) was first identified from porcine brain in 1982, and plays its biological functions in humans through NPY receptors (Y1, Y2, Y4 and Y5). NPY receptors are known to mediate various physiological functions and involve in a majority of human diseases, such as obesity, hypertension, epilepsy and metabolic disorders. Recently, NPY receptors have been found to be overexpressed in many cancers, so they emerged as promising target in cancer diagnosis and therapy. This review focuses on the latest research about NPY and NPY receptors, and summarizes the current knowledge on NPY receptors expression in cancers, selective ligands for NPY receptors and their application in cancer imaging and therapy.
Keywords: cancers; imaging; neuropeptide Y receptors; therapy.
References
-
- Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982;296:659–60. - PubMed
-
- Schwartz TW, Fuhlendorff J, Kjems LL, et al. Signal epitopes in the three-dimensional structure of neuropeptide Y. Interaction with Y1, Y2, and pancreatic polypeptide receptors. Ann N Y Acad Sci 1990;611:35–47. - PubMed
-
- Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004;38:213–24. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
